SPRY Investors Have Opportunity to Lead ARS Pharmaceuticals, Inc. Securities Fraud Lawsuit with SBS Law
Schall, Brown & Schwartz LLP issued a solicitation notice reminding SPRY investors of a lead-plaintiff deadline of October 5, 2026 in a securities class action against ARS Pharmaceuticals. The complaint alleges misleading statements about the timeline for insurance coverage of neffy following CVS Caremark's formulary addition, covering a class period of March 9 to June 24, 2026.
AI analysis
Red flags1 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.